$LIFE

GV 2019 GP, L.L.C. sold $1.8M of LIFE (indirect holdings)

GV 2019 GP, L.L.C. sold 94,087 indirectly-held shares of Ethos Technologies Inc. (LIFE) at an average of $19.47 ($18.73–$19.84, $1.83M total) across 3 trades over 2026-07-15 to 2026-07-16.

Original reporting
SEC EDGAR · GV 2019 GP, L.L.C.
Published Jul 18, 2026, 12:12 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 18, 2026, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LIFE
Bearish
medium confidence
Mentioned
$LIFE
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LIFEBearishLow
01

Why it matters

The newest fact is the disclosed open-market sale totaling $1.83M across 94,087 shares at a weighted average of $19.4681, with holdings reduced to 0 shares.

02

Market read

Traders may monitor for sentiment impact from a large owner exiting, but the filing alone does not change fundamentals.

03

What to watch

The filing specifies indirect holdings and post-sale 0 shares, but provides no reason for the sale or any concurrent company news, limiting causal inference.

Relevance 6/10Novelty 5/10Timing: after-hours/next session following the Form 4 filing disclosure (filed 2026-07-17)

Background

The article is an SEC Form 4 insider transaction disclosure for Ethos Technologies Inc. (LIFE) by GV 2019 GP, L.L.C., identified as a 10% owner.

Company-level read

Ticker impact

$LIFEBearishMedium confidence
Context

GV 2019 GP, L.L.C., a 10% owner, sold $1.83M of LIFE via open-market transactions at $18.73 to $19.84 per share, leaving 0 shares.

Expected impact

Near-term: slight bearish bias possible on liquidity/sentiment, but likely limited follow-through absent additional company-specific catalysts.

Evidence & confidence

Form 4 shows a completed sale across three trades and post-transaction holdings of 0 shares, but it does not include new operating, guidance, or regulatory information.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

A 10b5-1 plan is not indicated, but the sale could be routine liquidity management rather than a negative view on fundamentals.

Key entities

  • Ethos Technologies Inc.

    Subject of the Form 4 insider transaction disclosure (ticker LIFE).

  • GV 2019 GP, L.L.C.

    10% owner who sold 94,087 shares indirectly via open-market sale transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LIFEMed

Ethos (LIFE) Grows Revenue 113% While Margins Quietly Compress

Ethos Technologies (LIFE) reported Q2 revenue growth of 113% to $189.6M, with new policies up 133%. Gross profit margin was 98%, but net income rose only 5% to $19.5M. The company authorized a $100M stock buyback. Q3 revenue guidance is $160M-$164M, and full-year guidance is $727M-$731M. Margins compressed, with GAAP net loss of $146.9M for H1 2026 due to stock-based compensation.

$LIFEMedAI 9/10

Ethos (LIFE) Q2 2026 Earnings Call Transcript

Ethos Technologies (LIFE) reported Q2 2026 revenue of $189.6 million, up 113% Y/Y, with direct revenue $116.5 million (+131%) and third-party revenue $73.1 million (+90%). Adjusted EBITDA was $35.2 million (19% margin). Net income was $19.5 million. Full-year 2026 guidance: revenue $727-$731 million and adjusted EBITDA $119-$123 million. Up to $100 million Class A repurchase authorized.

$LIFEMed

Top SMid Cap Pick: Ethos Technologies Leads Citi’s Rankings

Citi analyst Ronald Josey named Ethos Technologies (LIFE) his top SMID-cap pick after the company’s Q2 results. Activated policies growth accelerated to 133% YoY, with 107,800 net activated policies. Revenue rose to $189.6M (+113% YoY). Ethos raised 2026 revenue guidance to $727M-$731M and adjusted EBITDA to $119M-$123M. Citi lifted its price target to $33 and kept Buy/High Risk.

$LIFEHigh

Ethos Technologies Inc. (LIFE): Results of Operations and Financial Condition

Ethos Technologies Inc. (LIFE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ethos Reports Second Quarter Fiscal Year 2026 Financial Results • Q2 Revenue grew 113% year-over-year to $190 million • Q2 Direct Channel Revenue grew 131% year-over-year to $116 million • Q2 Third-Party Revenue grew 90% year-over-year to $73 million • Board of Direc